NCT02466178View on ClinicalTrials.gov

Efficacy Trial for the Reduction of Glabellar Lines

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

December 31, 2016

Conditions
Rhytids in the Glabellar Region
Interventions
DEVICE

Serene RF System

The Serene RF System provides percutaneous delivery of radiofrequency (RF) energy to a targeted nerve.

Trial Locations (5)

10025

Aesthetic Plastic Surgery, New York

94401

Premier Plastic Surgery, San Mateo

97015

Reviance Plastic Surgery & Aesthetics Center, Clackamas

98033

Puget Sound Plastic Surgery, Kirkland

94306-3811

Premier Plastic Surgery, Palo Alto

All Listed Sponsors
lead

Serene Medical Inc

INDUSTRY

NCT02466178 - Efficacy Trial for the Reduction of Glabellar Lines | Biotech Hunter | Biotech Hunter